Skip to main content
. 2022 Sep 20;14(4):748–770. doi: 10.3390/neurolint14040063
AIS Acute Ischaemic Stroke
IVT Intravenous Thrombolysis
EVT Endovascular Thrombectomy
RBC Red Blood Cell
LAA Large Artery Atherosclerosis
HMCAS Hyperdense Middle Cerebral Artery Sign
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
TICI Thrombolysis in Cerebral Infarction
WBC White Blood Cell
SMD Standard Mean Difference
TOAST Trial of Org 10,172 in Acute Stroke Treatment
SVS Susceptibility Vessel Sign
r-tPA Recombinant Tissue Plasminogen Activator
H&E Haematoxylin and Eosin
MSB Martius Scarlet Blue
EVG Elastica van Gieson